News Focus
News Focus
Followers 4
Posts 222
Boards Moderated 0
Alias Born 12/20/2011

Re: baytdr post# 203123

Thursday, 11/09/2017 8:12:50 AM

Thursday, November 09, 2017 8:12:50 AM

Post# of 405172
Successful trials yielding partnerships is obviously paramount. Private placement with known successful biotech investors (angels) would be next followed by PP with private unknown investors and Aspire must be considered better than nothing but is not optimal for investors in the current environment. Trial results therefore trump every other possibility. Not long to wait for B-OM.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y